A recent study published in the journal Scientific Reports evaluated the durability of neutralizing antibody (nAb) responses induced after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering immune responses and sustaining protection, according to an analysis ...

When evaluating risks of thrombosis and thrombocytopenia individually across the various COVID-19 vaccines, there are some differences between the adenovirus- and mRNA-based shots, although risk of ...

Guillain–Barré syndrome (GBS) after COVID-19 vaccination is more common among individuals receiving adenovirus-vectored vaccines compared with mRNA vaccines. Investigators conducted a systematic ...

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...

The mRNA vaccines we are currently using are not sufficient to stop the ongoing Covid-19 pandemic. Although they have been critical in the fight against SARS-CoV-2, they suffer from a glaring ...

Even before the World Health Organization declared the COVID-19 outbreak a pandemic on March 11, 2020, the scientific community was mobilizing to develop vaccines with the hope of protecting us all.

A study published by The BMJ today sheds further light on the risk of developing a very rare blood-clotting condition known as thrombosis with thrombocytopenia syndrome (TTS) after vaccination against ...